In an interview with CNBC-TV18, Krishna Bodanapu, CEO and MD of Cyient said that capacity output in Q3 was low due to fewer working days which resulted in a weak quarter. However, he expects ...

Signature Global records 120% YoY growth in Q3 pre-sales at Rs 2,770 crore ... followed by L&T Tech, Cyient, Tata Elxsi, and Tata Tech. Campbell Wilson, CEO and MD of Air India said the approval ...

Cyient DLM had appointed M/s KPMG as internal auditors for the Financial Year 2023-2024. KPMG carried out the internal audit based on an internal audit plan, which is reviewed each year and ...

Cyient announced the appointment of K. A. Prabhakaran as Senior Vice President and Chief Technology Officer of its DET business. Prabhakaran is an accomplished professional in the engineering & ...

It’s important to carefully check the trims of the car you’re interested in to make sure that you’re getting the features you want, and aren’t overpaying for those you don’t want. Our ...

Dividend announcements are not available. No other corporate actions details are available.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Alembic Pharmaceuticals shares slipped 2.8 per cent on BSE, logging an intraday low at Rs 821.65 per share. The selling pressure on the counter came after the US Food and Drugs Administration (US FDA) ...

Cyient DLM Ltd. is a Public Limited Listed company incorporated on 30/06/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...